Quarterly financial statements

Hims & Hers Health Adds GLP-1 Injections for Weight Loss, Stock Soars 30%

May 20, 2024, 01:26 PM

Hims & Hers Health has announced the addition of compounded GLP-1 injections to its weight loss program. The news has positively impacted the company's stock, with $HIMS experiencing a significant increase in value. The stock saw a 10% rise shortly after the announcement and later spiked by 20%. By the end of the day, $HIMS was up 30%. This move positions Hims & Hers Health to offer both compounded GLP-1 weight loss treatments and mainstream options, potentially expanding its market reach in a big market.